Cytomine
0670.792.612 · rovalta.com · 24/09/2026
NORMAL SITUATION
Cytomine
Company — Normal situation.
Financial year 2024 · Closed on 31/12/2024
Net result
-247,4 k €
-8 519,6 %over 1 yearGross margin
3,8 k €
+2,9 %over 1 yearEquity
1,9 k €
-99,2 %over 1 yearOverview
Identity
Source · BCE/KBOCytomine is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0670.792.612
- Legal form
- Cooperative society
- Contributed capital
- 490 000,00 €
- Latest accounts
- 31/12/2024
Joint committees (1)
- 200
Signals
Good liquidityPositive EBITDA
Financials
Source · NBB, 8 filingsTrend over 8 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 3,8 k € | +2.9% | 3,7 k € | +171% | -5,3 k € | -102% | 223 k € | +1278% | 16,2 k € |
| EBITDA | 2,7 k € | -12.4% | 3 k € | +153% | -5,7 k € | -103% | 218,8 k € | +1293% | 15,7 k € |
| Operating result | 2,7 k € | -12.4% | 3 k € | +153% | -5,7 k € | -103% | 218,5 k € | +2611% | 8,1 k € |
| Net result | -247,4 k € | -8520% | 2,9 k € | +227% | -2,3 k € | -101% | 218,4 k € | +2641% | 8 k € |
| Balance sheet | |||||||||
| Equity | 1,9 k € | -99.2% | 249,4 k € | +1.2% | 246,4 k € | -0.9% | 248,7 k € | +719% | 30,4 k € |
| Total assets | 7,2 k € | -97.2% | 261,8 k € | -0.4% | 262,8 k € | -2.3% | 269,1 k € | +207% | 87,7 k € |
| Cash | 6,9 k € | -40.0% | 11,5 k € | -10.0% | 12,8 k € | -32.2% | 18,8 k € | -28.3% | 26,3 k € |
| Debts | 430,8 € | -96.5% | 12,4 k € | -24.2% | 16,4 k € | -19.5% | 20,4 k € | -64.0% | 56,5 k € |
| Other | |||||||||
| Workforce | – | – | 0,0 ETP | 0,0 ETP | – | ||||
Board of directors
Source · NBB, accounts to 31/12/20243 active · 9 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 28/03/2025 | 24/05/2024 | 25/05/2023 | 24/05/2022 | 11/08/2021 | 29/07/2020 |
| General meeting | 10/03/2025 | 11/05/2024 | 13/05/2023 | 14/05/2022 | 12/05/2021 | 18/07/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 8 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2024 | 10/03/2025 | 28/03/2025 | French | |
| Abridged model | 31/12/2023 | 11/05/2024 | 24/05/2024 | French | |
| Abridged model | 31/12/2022 | 13/05/2023 | 25/05/2023 | French | |
| Abridged model | 31/12/2021 | 14/05/2022 | 24/05/2022 | French | |
| Abridged model | 31/12/2020 | 12/05/2021 | 11/08/2021 | French | |
| Abridged model | 31/12/2019 | 18/07/2020 | 29/07/2020 | French | |
| Abridged model | 31/12/2018 | 11/05/2019 | 18/06/2019 | French | |
| Abridged model | 31/12/2017 | 12/05/2018 | 30/07/2018 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20243 active · 9 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Dissolution01/04/2025RUBRIQUE FIN (CESSATION, ANNULATION CESSATION, NULLITE, CONC, REORGANISATION JUDICIAIRE, ETC...)
- Mandates05/07/2024DEMISSIONS, NOMINATIONS
- Mandates26/06/2024DEMISSIONS, NOMINATIONS
- Registered office05/10/2021SIEGE SOCIAL
- Other01/07/2021STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE
- Mandates22/06/2021DEMISSIONS, NOMINATIONS
- Mandates03/06/2021DEMISSIONS, NOMINATIONS
- Mandates12/08/2020DEMISSIONS, NOMINATIONS
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 2024-247,4 k €↓
- 2023Annual accounts 20232,9 k €↑
- 2022Annual accounts 2022-2,3 k €↓
- 2022Name changeCYTOMINE
- 2021Annual accounts 2021218,4 k €↑
- 2021Name changeCytomine SC
- 2020Annual accounts 20208 k €↑
- 2019Annual accounts 2019-61,2 k €↑
- 2018Annual accounts 2018-344,3 k €↓
- 2017Annual accounts 2017-62,2 k €